ByDonovan Jones, IPOs, tech, alternative investments, CEO VentureDeal.com
G Medical Innovations has proposed terms for a $15 million U.S. IPO.
The company is commercializing cardiovascular monitoring technologies.
GMVD has promising technologies but the IPO is extremely high-priced; investors may wish to watch list the stock and look for a lower entry point post-IPO.
The company is commercializing cardiovascular monitoring solutions.
GMVD has begun commercializing its lead product, but the IPO appears overpriced; interested investors may wish to exercise patience and wait for a potentially lower price after the IPO.
Company & Technology
Tel Aviv, Israel-based G Medical was founded in 2014 to provide a suite of e-health software solutions and mobile monitoring devices that help clinicians increase the level of support and care while supporting preventative medicine.
Management is headed by President, CEO and Director Yacov Geva, who has been with the firm since 2014 and has previously founded LifeWatch.
G Medical has developed the Prizma Medical Smartphone Case, a phone case that allows individuals to turn their phones into medical monitors and share their information with their doctors, including: